Creative Biolabs-Immuno-oncology

Anti-Gliadin (clone 1G0Z0Z2E-1GE0Z1G) SynExpress E1-Cy3-β-Sm Modified CD8+ T cells (CAT#: ITS-1224-CR508)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target Gliadin (clone 1G0Z0Z2E-1GE0Z1G). We employs the AAV (EF1α-Cy3-β-catenin-SmaI) vector components and the SynExpress system of the Exons Deletion/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
Gliadin
Clone
1G0Z0Z2E-1GE0Z1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
EF1α
Effector Gene
β-catenin
Insertion Sites
SmaI
Gene Modification
Deletion
Modification Domain
Exons
Carrier Type
AAV
Transformation Accuracy
0.95
Cell Culture
Suspension Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving